Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Accelerated Approval Review Asks If Reg Gives De Facto Exclusivity

Jan 20 2003

• By The Pink Sheet

Related Content

Iressa User Fee Date Pushed To May; Will Advisory Cmte. Take Second Look?

Jan 13 2003

Accelerated Approval Standards Will Be Advisory Committee Topic In March

Dec 16 2002

Corixa/GSK Will Submit Bexxar-Zevalin Trial Protocol To FDA In January

Dec 23 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window